Clover Health Investments (CLOV) Operating Expenses (2019 - 2026)

Clover Health Investments has reported Operating Expenses for 8 years, with the latest figure at $721.9 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Expenses rose 55.7% year-over-year to $721.9 million; the trailing twelve-month figure through Mar 2026 stood at $2.3 billion (up 50.12% YoY), and the FY2025 full-year result was $2.0 billion, up 41.85% from the prior year.
• Operating Expenses for Q1 2026 stood at $721.9 million, up from $537.0 million in the prior quarter.
• The five-year high for Operating Expenses was $961.9 million in Q1 2022, with the low at -$1.5 billion in Q4 2022.
• Historically, Operating Expenses has averaged $411.6 million across 5 years, with a median of $401.7 million in 2023.
• The largest YoY upside for Operating Expenses was 201.13% in 2022 against a maximum downside of 335.77% in 2022.
• Clover Health Investments' Operating Expenses stood at -$1.5 billion in 2022, then jumped by 125.74% to $375.5 million in 2023, then fell by 4.56% to $358.4 million in 2024, then jumped by 49.84% to $537.0 million in 2025, then surged by 34.42% to $721.9 million in 2026.
• The last three Operating Expenses figures came in at $721.9 million (Q1 2026), $537.0 million (Q4 2025), and $521.0 million (Q3 2025), per Business Quant data.